Masuda N, Bando H, Yamanaka T, Kadoya T, et al. Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer
patients stratified by homologous recombination deficiency status: a multicenter
randomized phase II clinical trial. Breast Cancer Res Treat 2021 Mar 25. pii: 10.1007/s10549-021-06184.
PMID: 33763789